statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CalciMedica (CALC Research Report), Apollomics (AP...

Analysts Offer Insights on Healthcare Companies: CalciMedica (CALC), Apollomics (APLM) and Iterum Therapeutics (ITRM)

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Apollomics price target lowered by $12 at H.C. Wainwright, here's why

Apollomics reports FY23 EPS ($2.32) vs ($8.44) last year

Continued clinical and regulatory progress for the vebreltinib (APL-101) registration-enabling programCompleted patient enrollment for the uproleselan (APL-106) Phase 3 bridging study in China...

Apollomics Highlights Clinical Progress and Reports Full Year 2023 Financial Results

Apollomics, Inc. (APLM) Q4 2023 Earnings Call Transcript...

Apollomics, Inc. (APLM) Q4 2023 Earnings Call Transcript

Apollomics, Inc. (NASDAQ:APLM  Get Free Report) was the recipient of a large increase in short interest in February. As of February 29th, there was short interest totalling 43,900 shares, an...

Apollomics, Inc. (NASDAQ:APLM) Short Interest Up 121.7% in February

Apollomics appoints Plunkett as CFO

Apollomics receives Nasdaq notification regarding minimum bid price deficiency...

Apollomics receives Nasdaq notification regarding minimum bid price deficiency

Apollomics has an initial 180-day period through July 15, 2024 to regain compliance with Minimum Bid Price RequirementFOSTER CITY, Calif., Jan. 19, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq...

Apollomics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company was founded by Liang Yu Guo and Sanjeev Redkar in 2015 and is headquartered in Foster City, CA.

Watchers	1,422
52-Wk Low	$0.388
52-Wk High	$6.45

Volume	275.00
52-Wk High	$6.45
52-Wk Low	$0.388

APLM Apollomics Inc - Ordinary Shares - Class A

About

Feed

News

Fundamentals